Austin, Texas May Let Some First Responders Use Medical Cannabis

3/29/2022

by

a word from our sponsors:

advertisement

advertise here

The Austin, Texas City Council Public Safety Committee is considering allowing some city employed first responders to use medical cannabis, FOX 7 reports. If approved, the policy would cover all first responders except those that carry firearms – such as police officers and arson investigators – and those who operate commercial vehicles due to federal prohibition.

The policy would also prohibit the use of any THC on the job, which is prohibited under the federal Drug-Free Workplace Act.

Assistant City Manager Ray Arellano said the state’s medical cannabis law is “silent” on whether registered patients are permitted to use low-THC products at work. He looked at other cities’ medical cannabis policies and found that, of the 20 cities surveyed, only Boston allows medical cannabis use among first responders – nine cities surveyed do not allow it while 10 did not respond.

“I think what we’re trying to do is find a solution that keeps us square with all the regulations that are out there.” – Arellano to FOX 7

The proposal comes as some city agencies, like Austin Police Department and Austin-Travis County EMS face staffing shortages; EMS in November removed a question from their applications about prior cannabis use but first responders can still be fired if they test positive for cannabis on a drug test.

Arellano said he would defer to individual agencies to address the issue during the contract negotiation process but a specific measure has not yet been introduced to the council.

End

How to Get the Most Out of B2B Cannabis Events

3/29/2022

by

a word from our sponsors:

advertisement

advertise here

Business-to-business (B2B) cannabis conferences are an extremely useful resource for cannabis entrepreneurs at any stage of launching and/or operating their business. Whether you are attending your first-ever cannabis conference this year or you are returning to the events circuit after a pandemic-driven hiatus, this is a guide to help you get the most out of your ticket.

Setting your expectations

While cannabis consumption is not necessarily prohibited at these B2B conferences (although it frequently is, due to either state law or restrictions set by the hosting venue), these are not typically consumption-focused events. It is important to set this expectation so neither you nor anyone on your team is surprised or disappointed with their event experience.

That said, it’s not like attendees are going to be offended by some light cannabis use and you’re unlikely to be ostracized if someone spies you sipping on a vape pen outside (note: this can of course vary to a degree, depending on the city and/or venue). The bottom line is that one must “know thyself” — i.e. make your own call on consumption. Just remember that most of the people attending these events are either there on the clock as a representative for their company or brand, or they are there to both develop themselves professionally and expand their industry knowledge.

Our last tip here is to consider saving your smoking circles for the after-parties! (More on those, later).

Endless opportunities to learn

B2B cannabis events offer a wealth of educational opportunities including keynote speaker presentations and topic-specific seminars featuring industry experts at the top of their fields. Such seminars also typically end with open Q&A sessions so you can get answers to your questions directly from the masters of their craft. Some events even offer roundtable discussions where you can get your answers in a more intimate/efficient setting — but if not, there is plenty of opportunity for gathering peer-to-peer knowledge by networking on the exhibition floor!

The latest trends on display

From advanced robotics to the latest in grow light technology, the cannabis space is a petri dish for innovation and cannabis industry events are where service providers and inventors go to show off their latest goods. You never know what you’re going to see; it could be the latest development in nano-emulsification technology, the newest fish-based fertilizer to hit the market, or something way out of left field — like a fleet of flying robots to monitor your massive industrial hemp crop — if it’s new and successful, it’s going to be a hit for the industry.

Business-to-business cannabis conferences are often where these trends are first proven or discovered.

From keynote addresses to intimate Q&A sessions with the industry’s leading experts, B2B conferences are an excellent resource for the modern cannabis entrepreneur.

Exhibiting your brand

While attendees obviously stand to gain a lot from their trip to a cannabis conference, there are also enormous benefits to being an exhibitor at one of these events. The ability to put your brand and/or product face-to-face with hundreds if not thousands of potential purchasers can be worth the asking price of exhibition alone, but there are other advantages.

“Networking” at these events, for example, is often more than just meeting new people or collecting business cards — some businesses at these shows are conducting wholesale purchases on the exhibition floor, signing new partnerships, meeting and securing investors, and more. Even though they may have paid for admission or an exhibition booth, a particularly successful conference will generate huge savings for a brand in the long run due to these special opportunities.

Some tips for networking

Nearly everyone at a B2B cannabis conference is going to be after the same thing: expanding their knowledge of the industry and pursuing new, fruitful partnerships.

Here are some final tips to consider as we return to the B2B events circuit:

  • You’re going to see more ancillary businesses on display — such as accountants, insurance agents, packaging firms, security consultants, etc. — than you will actual cannabis entrepreneurs (and that’s by design). People in attendance, however, are much more likely to be “touch-the-plant” entrepreneurs, or at least considering such a career.
  • Cannabis is going mainstream, so don’t be surprised to encounter representatives from the more “mainstream” brands you would find in any other industry. They might even be attending their first-ever cannabis industry event, so be friendly and say “hello” — they are probably just as excited as you!
  • Don’t forget about the after-parties! There is an impressive amount of business networking that goes on during the after-hour parties that inevitably crop up around a B2B cannabis conference. Keep your eyes and ears out if this sounds like something you would enjoy — lots of times, these parties will be arranged by brands who are local to the area, and sometimes even by the event coordinators themselves.

Conclusion

Our final recommendation is simply to remember to approach each event with a goal or list of goals that you hope to achieve. Whether it’s finding some new investment dollars, connecting with a staffing agency, or just learning more about the cannabis cultivation process from experts at the top of their field, cannabis industry conferences are an excellent and exciting resource.

Bottom line: in-person events are back! It’s time to make your plan and get back to doing business.

End

U.S. House Poised to Approve Federal Cannabis Legalization

3/28/2022

by

a word from our sponsors:

advertisement

advertise here

The U.S. House is set to vote this week on the MORE Act, which would legalize cannabis federally, The Hill reports. The vote could come as soon as Wednesday, and the Democrat-controlled chamber has the votes to pass the broad reform package.

Last week the Senate unanimously passed a bill to expand scientific and medical research on cannabis and last month the House passed the SAFE Banking Act for the sixth time, which would allow cannabis businesses access to traditional financial services from which they are currently blocked due to federal prohibition; the Senate, which is narrowly controlled by Democrats, has never taken up the proposal.

Rep. Earl Blumenauer (D-OR), a co-chair of the Congressional Cannabis Caucus, told The Hill that this Congress “represents a sea change” on cannabis policy.

“What we have seen is that the majority of people now realize that the War on Drugs failed. Drugs are more accessible and cheaper and more potent and dangerous. Nobody won this war, except people who were involved with the drug dealers themselves.” – Blumenauer to The Hill

The MORE Act – or the Marijuana Opportunity Reinvestment and Expungement Act – would establish a process to expunge nonviolent federal cannabis convictions and impose a federal tax on cannabis sales that would be used to fund programs to help communities negatively impacted by the war on drugs.

The chamber passed the legislation in December 2020 by a 228 to 164 margin with five Republicans crossing party lines to vote in favor and six Democrats joining the opposition. One of the Republicans, Rep. Don Young (AK), who voted for the bill died last week and Blumenauer said the margin “might be tighter” for the vote.

A Pew Research Center poll from last April found 91% of U.S. adults said cannabis should be legalized federally, with 60% saying it should be legalized for both medical and adult use and 31% saying it should only be legalized for medical purposes.

End

Georgia Police Forced to Return Cash and Hemp-Derived Products Seized During Raids

3/28/2022

by

a word from our sponsors:

advertisement

advertise here

Law enforcement agencies in Georgia are being forced to return hemp-derived products they seized during recent raids, Channel 2 Action News reports. The products range from CBD to hemp-derived THC products, such as delta-8, that are considered legal under the state’s hemp law.

In November, the Madison County Sheriff’s Office raided Sahil Kumar’s grocery store in Danielsville and seized all of their delta-8 and CBD products – worth $30,000 – along with all of the money in his register.

“He took cash out of my register, and my cousin was there, and he had cash in his pocket. For two days, I couldn’t sleep, because I’m thinking in my mind, ‘We’ve done something wrong, we’re going to go to jail for breaking the law.’” – Kumar to Channel 2

Kumar’s products and cash were ultimately returned after he hired an attorney, Devin Rafus, who proved the products were legal and that deputies didn’t understand the state’s hemp law.

“Because the label has THC on it, law enforcement or the prosecutor’s office thinks it must be illegal because we all think it’s delta-9, which is illegal,” Rafus told Channel 2.

Earlier this month, Fulton County, Georgia Superior Court Judge Craig Schwall issued a 30-day restraining order against Gwinnett County District Attorney Patsy Austin-Gaston from prosecuting people for selling or possessing delta-8 and delta-10 extracts. In his ruling, Schwall questioned whether Austin-Gaston was acting as a “rogue DA.”

A lawsuit has been filed against Austin-Gaston and the state by companies that were subject to over-enforcement.

End

Michigan Cannabis Sales Reach $1B During Fiscal Year 2021

3/28/2022

by

a word from our sponsors:

advertisement

advertise here

Michigan cannabis sales topped $1 billion during the fiscal year 2021 which equates to $42.2 million distributed to the state’s municipalities, the Oakland Press reports. In the fiscal year, the state collected $111 million from the 10% excise tax on cannabis sales and other fees and the state had $172 million available for distribution from the Marijuana Regulation Fund.

State Treasurer Rachael Eubanks said the funds represent a “doubling” over last year’s payment amounts which she said, “will have a larger impact on local government budgets.”

In all, 62 cities with 262 adult-use cannabis retailers and microbusiness licensees will split $14.7 million; 15 villages with 31 adult-use cannabis retailers and microbusiness licensees will split $1.7 million; 33 townships with 81 adult-use cannabis retailers and microbusiness licensees will split $4.5 million, and 53 counties with 374 adult-use cannabis retailer and microbusiness licensees will split $21.1 million, the report says.

Another $49.3 million from cannabis taxes and fees will be sent to the School Aid Fund for K-12 education and another $49.3 million to the Michigan Transportation Fund once appropriated by lawmakers. The remaining $31.2 million will be used toward start-up and administrative costs.

Marijuana Regulatory Agency Executive Director Andrew Brisbo told the Press that it is “rewarding to see that the agency’s balanced regulatory approach is effectively protecting consumers while still allowing Michigan businesses to grow and thrive.”

“The funding provided directly to local governments – and the thousands of jobs created across the state – show that Michigan is leading the way in the cannabis industry,” he said.

End

New York Potency Tax Could Drive Prices as High as $70 an Eighth

3/25/2022

by

a word from our sponsors:

advertisement

advertise here

New York’s adult-use cannabis law includes a potency tax, which, in addition to the state’s sales and local taxes, could drive the price per eighth as high as $70, Syracuse.com reports. The law taxes distributors half a cent per milligram of the amount of total THC for flower, eight-tenths of one cent per milligram for concentrates, and three cents per milligram of THC for edibles.

The state’s sales tax rate is 9% and localities can impose their own taxes as well, which could raise the overall tax rate for flower as high as 30% or as much as 55% for edibles, said tax attorney Jason Klimek, who co-leads the Cannabis Team at law firm Barclay Damon.

By comparison, neighboring Massachusetts has a maximum 20% tax rate which is tied to sales which could put New York at a competitive disadvantage once sales launch. The state is also home to several Native American tribes, some of which have already launched cannabis sales, and carry no taxes.

Kaelan Castetter, founder of business consulting firm Castetter Cannabis Group and co-founder of the New York Cannabis Growers and Processors Association, told Syracuse.com that including a potency tax could also work to squeeze out smaller operators who are not in the financial positions of large multistate operators who would be able to withstand the tax and still offer competitive prices.

“Really, you’re setting up cultivators to be in a position down the line where they’re not able to eke out a profit, and the ones that will are the biggest ones.” – Castetter to Syracuse.com

Lauren Rudick, co-founder of law firm Hiller, PC’s cannabis law practice, said the THC tax could incentivize cultivators and distributors to offer products that are lower in THC but balance other cannabinoids and terpenes to create a better user experience and that it could offer an opportunity for the industry to better educate consumers who may think THC is solely responsible for the experience of a product.

“I see this as a tremendous opportunity for people to become educated on the endocannabinoid system,” she told Syracuse.com. “I think it’s going to spur some really unique product development.”

Ulrik Boesen, director of excise tax policy at The Tax Foundation, an independent tax policy nonprofit, said that the THC tax makes sense from the government’s perspective because, generally, cannabis markets start out hot but sales fall as markets mature and since THC is one of the few commonalities between cannabis products, it seems logical to pin the tax to the molecule.

“It’s really hard for states to forecast revenue if it’s based on the price of a volatile commodity,” he said. “It’s much easier for them to forecast volume.”

New York lawmakers approved adult-use reforms last year but sales are not expected to commence in the state until 2023.

End

Ukraine’s ‘Freedom March’ Calls on Global Cannabis Industry for Wartime Assistance

3/25/2022

by

a word from our sponsors:

advertisement

advertise here

Cannabis legalization activists with the Freedom March campaign in Ukraine are calling on the global cannabis industry for donations to help the Ukrainian people in their fight to defend their lives and national sovereignty from neighboring Russia.

Originally founded in 2005, Freedom March is a cannabis advocacy group that pushes for reforming Ukraine’s cannabis laws, expanding access to medical cannabis, and which defends in court people accused of possessing cannabis products, which remain outlawed in Ukraine.

In a statement provided to Ganjapreneur, Nazarii Sovsun, a representative for Freedom March, described the effort:

“Today, with weapons in our hands, we have to defend our sovereignty and democracy, shining rays of hope at the uncertain future of the entire free world. This war was cast on Ukraine not just to steal our territories and resources and eradicate our population. This war is against freedom and identity, a threat that reaches beyond borders. We invite all cannabis professionals to stand by our side while we still resist.” — Sovsun, in a statement

The group says donations will go towards two primary efforts: first, supporting the children of slain soldiers and civilians who need medical and psychological care and financial support; and second, providing proper treatment for the patients of Ukraine including wounded soldiers and civilians, cancer patients, and “other vulnerable groups impacted by the war.”

Notably, Freedom March is soliciting the donations not through their own platform but via the Kyiv School of Economics (KSE), which has updated its website to describe a new humanitarian campaign “together with Ukrainian businesses and state-owned companies … to provide food supplies, transportation, refugees help for Ukrainian citizens affected by the war,” and to “purchase necessary medicines, first aid and protective kits for the State Emergency Service of Ukraine, Ukrainian Paramedic Association, and the Ukrainian Territorial Defense Forces to shield them against Russian aggression.”

Russia launched its military invasion of Ukraine 31 days ago on February 24, 2022, in what has become the first major war in Europe in decades. Since the invasion was launched, millions of refugees have fled the country while countless more have joined the resistance effort.

End

Detroit Delays Vote on Adult-Use Regulations

3/25/2022

by

a word from our sponsors:

advertisement

advertise here

The Detroit, Michigan City Council has again delayed a vote on its long-awaited adult-use cannabis regulations until April 5, MJBizDaily reports. Detroit first approved an initial set of rules in November 2020, but a residency requirement – the Detroit Legacy Applicant – in the ordinance was challenged in court in early 2021, delaying any action by the council; however, a judge recently tossed the residency requirement on the grounds it was “likely un-Constitutional.”

The council only began the rule revamp last month, says MJBizDaily.

The new plan includes the approval of 100 cannabis licenses, up from 76, half of which are reserved for social equity applicants. This is a change from the scrapped plan which said 50% of the licenses must go to so-called legacy applicants. At the time the ordinance was passed in 2020, Mayor Mike Duggan (D) called the residency requirement “by far the most controversial provision.” The city will not issue a license to any business unless half of the licenses in that category are Detroiters.

Although the language is different, the defunct legacy provision and the addition of social equity stipulations in Detroit’s adult-use regulations may accomplish the same goals. The suggestion that applicants must be from Detroit was included to correct the harms caused to Michigan communities by the war on drugs. Notably, Detroit City Councilman James Tate said in 2020 that the inclusion of the legacy program “was imperative” for officials to right the wrong.

“We have individuals who are making a very good living on marijuana today,” Tate said. “The same plant that created this situation of mass incarceration around our country in the city of Detroit, so this is an opportunity for us.”

End

Japan Sees Record Number of People Involved in Cannabis Crimes Last Year

3/25/2022

by

a word from our sponsors:

advertisement

advertise here

Japan saw a record 5,482 people involved in cannabis-related criminal cases last year, an increase of 448 the previous year, with 70% of offenders in their 20s or younger, Kyodo News reports. Overall, 5.6 individuals per 100,000 people were involved in cannabis-related offenses in 2021, which is nearly double the 3.0 rate in 2017.

Among all of the cases, 4,537 were for possession, 273 were for distribution, and 230 were for cultivation, the report says. In all, police confiscated about 726.9 pounds of cannabis in Japan in 2021.

Among the offenders, 186 were high school students, eight were in junior high school, with the youngest offenders aged 14; 2,823 individuals involved in cannabis offenses were in their 20s and 994 were under 20-years-old, according to National Police Agency data outlined by Kyodo News.

By age group, 14.9 per 100,000 people under 20-years-old were involved in cannabis cases, up from 4.1 in 2017, while 23.6 per 100,000 people in their 20s were involved, up from 9.4, according to police data.

In a survey of 829 drug offenders by the National Police Agency, more than 70% said they did not believe cannabis is harmful, the report says.

The number of all drug offenders in Japan did fall overall last year to 13,862 – a decrease of 217. The majority of cases last year, 7,824, were for “stimulant drugs,” such as amphetamine or methamphetamine, which is a decrease of 647 from the year prior.

Japan’s Cannabis Control Act criminalizes the import, export, or cultivation of cannabis and simple possession carries a sentence of up to five years, according to the law firm Ohara & Furukawa. Possession with the intent to profit is punishable by up to seven years imprisonment and/or up to a 2,000,000 yen fine. Growing, importing, or exporting cannabis in Japan can be punished with up to seven years in prison, and engaging in any of those acts with the intent to profit carries a punishment of up to 10 years imprisonment.

End

Pennsylvania Medical Cannabis Flower Prices Fall but Patients Not Seeing Relief

3/25/2022

by

a word from our sponsors:

advertisement

advertise here

The average wholesale price per gram for medical cannabis flower in Pennsylvania has declined 36% since the start of 2020 but the average retail price paid by patients is down just 14% over that same period, according to a Philadelphia Inquirer report. John Collins, the outgoing executive director of the state Office of Medical Marijuana (OMM), called the discrepancy “a red flag that needs to be investigated.”

At the beginning of 2020, the average price of medical cannabis was $10.19 per gram which fell to $6.56 last month; the average price paid by patients at the beginning of 2020 was $15.67 per gram, and that average price dropped about $2.20 last month to $13.40 per gram.

During a meeting of the Pennsylvania Medical Marijuana Advisory Board, Collins said there wasn’t much the OMM could do about the price discrepancy.

“We can’t particularly force a price point. Dispensaries take title to the product and have the right to price it. What we can do to encourage more competition is to put a spotlight on it like we’re doing today.” – Collins, during the meeting, via the Inquirer

In an email to the Inquirer, Jeff Riedy, executive director of the Lehigh Valley chapter of the NORML, said advocates have long been seeking officials to act on “excessive pricing,” noting that the director’s “acknowledgment of pricing inequities exemplifies that industry players are concerned more about profits and less about helping” the state’s 400,000 active medical cannabis patients.

The state Health Department does have the legal authority to cap medical cannabis prices, but has so far declined to do so, the report says.

Meredith Buettner, executive director of the Pennsylvania Cannabis Coalition said Collins’ remarks “fail to recognize the regulatory reality of operating in Pennsylvania” and said the high prices are due to duplicative product testing requirements, the inability of operations to remediate contaminated cannabis into something else they can sell, and other regulatory factors.

End

Denver’s First Social Equity Consumption Lounge Receives License

3/24/2022

by

a word from our sponsors:

advertisement

advertise here

Tetra Lounge in Denver became the first social equity applicant to be licensed as a cannabis consumption lounge this week, pending inspections, according to a 9NEWS report.

Such lounges used to operate in Denver but after cannabis industry reforms in 2021, private companies were required to secure a license from the city to allow on-site consumption. Previously, Tetra Lounge had operated as a consumption lounge but had to close its doors following the new license requirements — after finally getting the license on Monday, however, owner Dewayne Benjamin told 9NEWS that he hopes to have the lounge open for business by 4/20.

“Getting the license really gives us the foundation to grow and keep establishing new experiences within the cannabis hospitality realm. There’s still a lot of financial aspects that kind of hinder a lot of businesses, but having the opportunity and the input into the industry I think is going to be very beneficial especially with new markets.” — Benjamin, in the report

Tetra Lounge will accept patrons at three different membership levels: daily membership will cost $20, monthly membership will cost $50, and annual membership will cost $350. The business will operate on a BYOC model, or “bring your own cannabis.”

Denver is currently issuing new cannabis licenses with an initial focus on social equity applicants. Two other proposed social equity establishments — the Patterson Inn and the Denver Weed Lounge — are still being considered by the city.

Meanwhile, the Tetra Lounge is set to join Denver’s only other operating cannabis lounge, The Coffee Joint, which received its license last week despite not being a social equity applicant because the city rules also prioritize pre-existing cannabis companies —The Coffee Joint was initially licensed by the city in 2018.

End

Medical Cannabis Sales in Arkansas Top $21.1M in February

3/24/2022

by

a word from our sponsors:

advertisement

advertise here

Medical cannabis sales in Arkansas totaled $21.1 million in February, an increase of more than $500,000 over January’s sales, according to state Department of Finance and Administration (DFA) figures outlined by Talk Business & Politics. The state collected $2.333 million in tax revenues from February sales – up from $2.309 million collected the previous month.

Since the first dispensary opened in Arkansas in May 2019, patients have purchased about 80,000 pounds of medical cannabis and the state has collected $62.525 million in taxes, which include a 6.5% sales tax and a 4% privilege tax on sales from cultivators to dispensaries, the report says. Most of the revenues are earmarked in the University of Arkansas for Medical Sciences National Cancer Designation Trust Fund.

DFA Spokesman Scott Hardin told Talk Business & Politics that medical cannabis sales “really started to increase beginning March 2021 through early fall.”

“We anticipate stimulus funding played a role. Although sales remain fairly strong today, we are not seeing the levels reached in spring and fall last year.” – Hardin to Talk Business & Politics

The Arkansas Department of Health reported 82,410 active patient cards in February, a slight decrease from 82,696 active patient cards in its January report.

Earlier this month, the state’s 38th licensed dispensary opened in Van Buren, and Hardin described the market in central Arkansas as “very competitive,” noting that there are now seven dispensaries within 30 minutes of Little Rock.

“As a region, northwest Arkansas leads the state with almost 800 pounds sold in February through the Fayetteville and Bentonville dispensaries,” Hardin said.

Natural Relief Dispensary in Sherwood reported the most February sales with 372 pounds, while The Releaf Center in Bentonville was second with 299 pounds, according to state data.

End

Local Cannabis Possession Reforms Advance In Tuscaloosa, Alabama

3/24/2022

by

a word from our sponsors:

advertisement

advertise here

The Tuscaloosa, Alabama City Council Public Safety Committee on Tuesday approved a measure proposed by the city’s police chief that would lower penalties for low-level cannabis crimes to a simple citation, according to a Patch report. Under the measure, second-degree cannabis possession, improper identification, possession of drug paraphernalia, and other low-level misdemeanor offenses would be reduced to citations.

Under current law, those charged with second-degree possession of cannabis face a maximum penalty of 180 days in the county jail and a fine not to exceed $500.

Tuscaloosa Police Chief Brent Blankley said law enforcement officials believe low-level cannabis possession and other crimes covered under the proposal “can be handled with a ticket” and would save officers time. However, he told the council that individuals who “fight or run” from police would still go to jail for the offense.

“Officers will still use officer discretion and it’s just like an open beverage [citation] we do now. It’s the same basis as that, so we’re hoping if you do have a dime bag in your car, we’ll pull you over and we’ll give you a ticket and you go on your way.” – Blankley to Patch

Under state law, those found guilty of misdemeanor cannabis possession face up to a year in prison and fines up to $6,000; the state spends $22 million in taxpayer money every year enforcing cannabis laws, the report says.

Blankley told Patch that he thinks the council “is in favor” of the proposal.

“We’re always trying to be innovative at the police department and this has always been something that’s weighed on us in the past,” he said. “Not as many people will actually go to jail and there is always overcrowding, so we think this will be much better for the community.”

The measure is expected to be considered by the full council next week and City Attorney Scott Holmes said that if it passes, the reforms would take effect June 1 or July 1.

End

Maine Legislative Committee Advances Three Medical Cannabis Bills

3/24/2022

by

a word from our sponsors:

advertisement

advertise here

The Maine Legislature’s Veterans and Legal Affairs Committee has advanced bills to ensure patients have access to telehealth services, allow caregivers to sell plants to patients, and asks for a legislative review of any patient privacy changes made by the Office of Marijuana Policy (OMP), according to a WABI report. Paul McCarrier, a member of the Cannabis Council of Maine, told WABI that the OMP was “working with the community and listening to us.”

He said the agency wants to collaborate “to keep the prices for patients fair and low and to make sure that patients can continue to access that therapeutic cannabis.”

This is the second iteration of the rules authored by the OMP after the first draft was scrapped due to industry outcry. The OMP has created a 17-member workgroup to help streamline licensing and compliance and to align the system more with state law, the site wrote in their report.

McCarrier said he appreciates the work the legislature has done to recognize medical cannabis and said the OPM will create a digital medical cannabis card similar to other digital forms of identification like insurance cards or other medical cards.

Maine is currently blocking the out-of-state ownership of medical cannabis businesses after a federal judge ruled the state had to begin granting cannabis licenses to out-of-state owners. Maine officials agreed to permit out-of-state owners for adult-use licenses, but have continued to block the cohort from their medical cannabis system.

End

Iowa Republicans Reject Bid to Add Adult-Use Cannabis Amendment to Drug Reform Bill

3/24/2022

by

a word from our sponsors:

advertisement

advertise here

Senate Democrats in Iowa attempted, unsuccessfully, to tack on an adult-use cannabis amendment to a bill concerning heroin penalties, Iowa Starting Line reports. The proposal was struck down without a hearing because it wasn’t related to the bill being debated.

The proposal, which would have amended the state constitution but eventually leave the final decision to voters, was introduced by Sen. Joe Bolkcom, who described Gov. Kim Reynolds’ (R) and Senate Republicans’ failure to even debate the issue or explain why they oppose the reforms as “insulting.” He also emphasized that cannabis prohibition disproportionately impacts Black Iowans and their families.

“You should tell Iowans why you don’t trust them to have legal access to marijuana like tens of millions of other Americans.” – Bolkcom, during the debate, via Starting Line

State Sen. Jackie Smith (D) said that the state would see $60 million to $100 million annually were the state to legalize cannabis for adults.

“Nineteen states now regulate marijuana like recreational alcohol. We’re surrounded by them,” she said during the debate. “And it was the voters in South Dakota that spoke during the 2020 elections to approve of marijuana use for adults. So I think giving voters a voice on this is what they want.”

A Des Moines Register/Mediacom Iowa poll from March 2021 found 54% of Iowa adults support the reforms, with 39% opposed and 6% unsure. The numbers are similar to a March 2020 poll, which found 53% support for broad legalization in the state, with 41% opposed.

End

Lolita Korneagay: Demystifying Cannabis for Medical Professionals

3/23/2022

by

a word from our sponsors:

advertisement

advertise here

Despite the medical cannabis industry’s rapid development, medical professionals are still entering the workforce with minimal cannabis knowledge and most are woefully unprepared to handle cannabis-related questions from their patients.

That was the starting point for Cansoom, which was founded by a medical professional, for medical professionals, to bridge the gap between the modern medical industry and the burgeoning cannabis movement. We recently interviewed Cansoom’s founder Lolita Korneagay about the company’s founding, building the curriculum for her educational programs, her inspiration to continue learning and teaching about the medicinal properties of cannabis, her advice — and new coaching course — for hopeful cannabis entrepreneurs, and more!

Find the full interview below:

Ganjapreneur: What inspired you to create Cansoom?

Lolita Korneagay: The inspiration for Cansoom comes from a personal need. Around 2012, I was diagnosed with multiple medical issues that caused severe pain, which had a significant impact on my quality of life. I tried everything to minimize the pain, including medical devices, high dosage pain pills, and invasive surgery. Nothing seemed to work. So eventually, I tried cannabis.

At first I was very hesitant to try a drug that had so much stigma attached to it. My entire life, I was told that cannabis is a drug and drugs are bad. But I knew that cannabis had medicinal properties that have been proven to help a wide variety of diseases and ailments. So I took the leap and began testing different dosages in order to create a treatment plan for myself. When I found my minimum effective dose, I was finally able to control my pain.

While I was doing research, I realized that my nursing education did not teach me about the endocannabinoid system, which is the foundation for using cannabis as a medicine. So I spent weeks learning about how it works and the role that cannabis can play in creating homeostasis within our body. This is when I realized that more medical professionals needed to learn this information and Cansoom was created.

Cansoom was founded on the idea that medical professionals, such as nurses, would go through training to become medical Cannabis Consultants, and then they would act as a conduit to pass along their medical cannabis expertise to their communities.

How did you build the curriculum for the Medical Cannabis Consultant program?

It took a lot of old-fashioned research to create the Cansoom curriculum. I attended cannabis conferences and took copious notes when I heard experts speak, I bought and read countless books that focused on the medical uses for cannabis, and I took a couple of classes to learn about the endocannabinoid system.

The biggest issue that I had while creating the curriculum was that there just wasn’t a lot of creditable information available at that time. So I had to really take my time to ensure that I was learning the proper information before I taught it to other people. This process took about a year.

Going through the tedious process helped me shape the curriculum because I wanted to make learning about cannabis easier. As a nurse, I knew that most medical professionals needed a comprehensive course that didn’t take a long time to complete. So that’s what I created. When I first launched in 2017, the Cansoom curriculum was the most comprehensive in-person training program that taught licensed medical professionals about medical cannabis.

Our understanding of the cannabis plant is growing quickly. Do you continue learning and developing the curriculum to reflect new findings?

Absolutely! I update my book, The Medical Cannabis Consultant’s Handbook, as the laws change and when new scientific discoveries are made. I especially like to learn and teach about the new cannabinoids that are being synthesized from hemp. These cannabinoids, like D8 and D10, are 100% legal and can provide some of the same benefits of D9. It’s important to me that my students know as much about the plant as possible so I always want to make sure that I stay on top of any new discoveries.

What do nurses, doctors, and therapists do next after completing the Medical Cannabis Consultant program?

After completing the Cansoom Medical Cannabis Consultant program, the possibilities for medical professionals are almost limitless. My program provides them with the foundational knowledge to enhance their current careers or start their own businesses.

Some of my previous students have started medical cannabis consulting businesses, written cannabis-related books, become cannabis influencers, produced cannabis-infused products, become cannabis advocates, started ancillary cannabis businesses, and they have become industry speakers.

I always tell my students that the cannabis industry is still new and you can create your own lane within it. I recommend that they find a way to combine their passion and professional knowledge to create a cannabis side-hustle, business, or career that they love.

When did you build the 12-week Cash In On Cannabis coaching program?

Since the beginning of Cansoom, my students have asked me for a course that taught them about the business-side of the cannabis industry. I’m a serial entrepreneur, so I know that the process of launching a new business is not as easy as it seems. Since I launched Cansoom five years ago, I’ve developed a set of processes and strategies that are tested and proven to work time after time.

This year, I decided that it was time to share my system with the world and so I launched the Cash In On Cannabis coaching program. It’s a 12-week coaching program that guarantees a student will launch their business idea within a month of completing the program.

What is the most valuable thing that students will take away from the coaching program?

I designed the program to overcome the biggest challenges I’ve seen people get stuck with and that I’ve had trouble with myself…things like choosing software programs, creating sales strategies, having a plan to follow, and being held accountable. So the most valuable thing that students will take away from participating in the program is that they will have a proven blueprint to follow that they could use for many years to come. They will know that they can do it and have the support they need to get it done.

What inspired you to plan the first Cansoom Medical Cannabis Conference?

Pre-pandemic all of my training classes were held in person in Los Angeles. During each class, everyone would always have such a good time and I would literally have to push people out of the door at 5 pm. The networking that occurred during the training classes was one of the valuable benefits of joining the Cansoom community of consultants. So my students started to ask for more time together.

Originally, I created the Cansoom Medical Cannabis Conference as a way for my previous students to continue to learn about cannabis while connecting with each other. The first conference in 2020 was a huge success with students from all over the country convening in Las Vegas for two days. We had so much fun and a lot of friendships were made that weekend.

Are there any new events or educational offerings on the calendar at the 2022 Conference?
We are still in the planning stages, but one of the benefits of completing the Cansoom program is that all students are encouraged to apply to speak at the conference. I want to help any of my students who want to launch speaking careers by giving them a platform to speak on. Therefore, I accept speaker proposals from my students before searching for speakers outside of the community.

I’ve been watching some of my student’s cannabis-careers mature and we have some stellar students with amazing niches and points of view. Such as Jasyra Hines, who teaches women how to improve their health with cannabis. Or Erica Danielle who teaches women how to medicate, masturbate, and meditate.

Who can attend the Conference?

Now that it is becoming safe to gather in large groups again, I plan on hosting the next conference later this year and I will open up to the general public, but the target audience will be licensed medical professionals.

As someone who left a high-profile career to build your own successful business, what is one essential piece of advice for a hopeful entrepreneur?

Outwit. Outplay. Outlast. Yes, that’s the motto from Survivor but it’s also what you must do to be a successful entrepreneur. Use your creativity to outwit your competition. Create strategies to outplay them. And if you can outlast them, you win!

Thank you, Lolita, for answering our questions! Our readers can visit Cansoom.com for more info.

End

Federal Bill Would Instruct UN to Deschedule Cannabis

3/23/2022

by

a word from our sponsors:

advertisement

advertise here

A bipartisan federal bill introduced last week would instruct the United Nations (U.N.) to deschedule cannabis from its Schedule 1 status in the Single Convention of Drugs of 1961 and treat it as a commodity similar to other agricultural products.

Republican Rep. Nancy Mace (S.C.) said that were the U.N. to deschedule cannabis, many other countries would reevaluate their own classifications of the plant.

“Cannabis has been shown to be effective in the treatment of numerous medical conditions such as epilepsy, PTSD, cancer pain relief, nausea, and chronic and terminal illnesses. Descheduling at the U.N. would support global research into how cannabis can treat a wide range of ailments and conditions.” — Mace in a statement

Democratic Rep. Barbara Lee (CA) said that cannabis’ classification “as a schedule one drug is outdated, out of touch, and should be addressed not only in the United States but around the world.”

“Scientific research has shown that cannabis has wide-ranging positive effects on chronic illness treatment,” she said in a statement. “The United States should be leading the way on cannabis reform on the global stage, and descheduling at the United Nations would be a great start.”

Mace is also the sponsor of the States Reform Act which aims to end the federal prohibition of cannabis in favor of a tax-and-regulate model similar to alcohol. That bill has the backing of retail giant Amazon.

“Like so many in this country,” Amazon Public Policy wrote on Twitter, “we believe it’s time to reform the nation’s cannabis policy, and Amazon is committed to helping lead the effort.”

In 2020, the U.N. Commission for Narcotic Drugs voted to reclassify cannabis’ status under the 1961 Single Convention and remove medical cannabis from Schedule IV but stopped short of declassifying the plant.

A 2018 report by the International Drug Policy Consortium found that the U.N.’s ‘war on drugs’ has not reduced the rates of drug use but has negatively affected human rights, health, security, and development around the world. Specifically, the report argues that the last decade of drug law enforcement led to heightened violence against police and civilians and the mass incarceration of otherwise innocent people.

End

Cresco Labs to Acquire Columbia Care in $2B Deal

3/23/2022

by

a word from our sponsors:

advertisement

advertise here

Cresco Labs has agreed to acquire Columbia Care Inc. in a deal worth $2 billion, making the firm largest multi-state operator in the U.S. with a pro-forma revenue of more than $1.4 billion.

The deal, which still requires regulatory approval, gives the company more than 130 retail stores throughout 18 states – the second largest in the industry and the largest footprint outside of Florida. On a pro-forma basis, Cresco said it expects to have annual revenues in excess of $100 million in eight different states by 2023.

Charles Bachtell, CEO of Cresco Labs, said the “acquisition brings together two of the leading operators in the industry, pairing a leading footprint with proven operational, brand and competitive excellence.”

“The combination is highly complementary and provides unmatched scale, depth, diversification and long-term growth. … [and] accelerates our journey to become the leader in cannabis in a way no other potential transaction could.” – Bachtell in a press release

Nicholas Vita, CEO of Columbia Care described the deal as a “historic moment.”

“With Columbia Care’s strategic national footprint in the most attractive markets and Cresco Labs’ success in execution and incredibly popular brands, we will together create the most important – and the most investable – company in cannabis,” he said in a statement.

The transaction has been unanimously approved by the boards of directors of each of Cresco Labs and Columbia Care.

Independently, the companies currently have the top share positions in four markets – including Illinois, Pennsylvania, Colorado, and Virginia, and a number two share in Massachusetts. The companies also said they have a pathway to a top-three position in New York, New Jersey, and Florida, which bring the combined company to a material market position in seven of the top 10 markets by revenue in 2025, according to cannabis industry analytics firm BDSA’s top-10 largest and fastest-growing markets by 2025, representing approximately 55% of the U.S. population and over 70% of the addressable cannabis market.

The transaction is the second-largest in the history of the U.S. cannabis industry – behind the $2.1 billion takeover of Harvest Health and Recreation by Trulieve Cannabis Corp. in October 2021.

End

Alabama Bill Would Require Women to Submit Pregnancy Test Before Purchasing Medical Cannabis

3/23/2022

by

a word from our sponsors:

advertisement

advertise here

A bill introduced in the Alabama Senate would require women of child-bearing age to submit a negative pregnancy test prior to buying their doctor-recommended medical cannabis, according to a Growth Op report. Under the proposal, women between the ages of 25 and 50 would be required to submit the negative test at least 48 hours before buying medical cannabis.

The pregnancy tests must be administered by a doctor or a state-certified lab, according to the report. If she becomes pregnant, a woman must “report her pregnancy status to her registered certifying physician and shall be prohibited from obtaining medical cannabis throughout the pregnancy.”

Sponsored by Alabama state Sen. Larry Stutts (R), the proposal “prohibits breastfeeding women from purchasing medical cannabis unless as a registered caregiver.” Additionally, the legislation adds a 305-meter buffer between medical cannabis dispensaries and schools, daycares, home daycares, and colleges.

Commenting on a case in Arizona in which the state charged a woman with child neglect for using medical cannabis, National Advocates for Pregnant Women wrote in a statement last summer that “Peer-reviewed scientific research does not support the conclusion that prenatal exposure to marijuana causes harm or creates risks of harm different or greater than exposure to many substances as well as medications prescribed to pregnant women.”

Oklahoma tried a similar change in 2018, but the call for a pregnancy test was eventually removed, the report says. If passed, the measure would take effect on the first day of the third month after passage.

End

Aurora Cannabis Acquires TerraFarma Inc. in $38M Deal

3/23/2022

by

a word from our sponsors:

advertisement

advertise here

Canadian firm Aurora Cannabis Inc. announced on Tuesday it had acquired Thrive Cannabis parent company TerraFarma Inc. in a cash and stock deal initially worth $38 million. Thrive will also be eligible for up to $20 million in shares, cash, or both if it reaches revenue targets within two years of the transaction.

Thrive is best known for its flagship adult-use brand, Greybeard Cannabis Co., which was recognized as the top-recommended brand by Canadian budtenders in 2021 and was the 2021 winner of Best Concentrate from the Kind Magazine Awards, as voted for by budtenders.

Aurora CEO Miguel Martin described Thrive’s track record as “seldom found elsewhere in the Canadian market.”

“They are truly exceptional cultivators who have gained trust with consumers and developed products that have been recognized and acclaimed by Canadian budtenders and industry peers. We see a unique opportunity to leverage their expertise to deliver near and long-term benefits for both our recreational and medical markets.” — Martin in a press release

Geoff Hoover, Thrive CEO, said the combining of the companies “will be transformative.”

“We are excited to be joining a team that shares our vision for delivering the highest quality, premium cannabis products to consumers in a way that generates sustainable profitability,” he said.

The transaction is expected to close, subject to customary closing conditions, in Aurora’s fiscal Q4 2022 and the firm anticipates that the deal will provide immediate positive adjusted EBITDA to Aurora, and support the company’s path to adjusted EBITDA profitability in the first half of fiscal 2023.

“This transaction supports our path to profitability while ensuring that we are strategic in our M&A activity,” Martin said in a statement. “Thrive’s achievement of positive standalone EBITDA, combined with their exceptional operational and brand capabilities, truly set them apart, and we look forward to leveraging their expertise as we embark together on Aurora’s path to profitability.”

End

Adult-Use Cannabis Sales Will Launch in New Mexico on April 1

3/22/2022

by

a word from our sponsors:

advertisement

advertise here

New Mexico’s first adult-use cannabis shops will open in the state on April 1, the Santa Fe New Mexican reports. Kristen Thomson, director of the Cannabis Control Division of the New Mexico Regulation and Licensing Department, said that the agency does “not have concerns about lack of product” in the nascent days of the state’s program.

“We really expect that first day of business to be filled with excitement. …  As with any new gadget or restaurant or something opening, some products may come up short, but we do not anticipate a massive statewide shortage of product on opening day.” – Thomson to the New Mexican

Thomson said that state officials have already approved 225 adult-use licenses, including some integrated licenses for businesses that produce, manufacture, deliver, and sell cannabis products and that some of those licenses cover more than one site.

The state’s law does require retailers to set aside 20% of their products for the medical cannabis program – which has nearly 132,000 enrolled patients as of February, according to state Department of Health figures outlined by the New Mexican. Emily Kaltenbach, senior state director of the Drug Policy Alliance, said that medical cannabis patients may have “more of a concern” about running out of product than adult-use customers.

Josh Foley, manager of a Pecos Valley Production dispensary, told the New Mexican he thought a shortage could occur in a few months but that his company is trying to store at least $500,000 worth of product to get them through “the first couple of months.”

Duke Rodriguez, president and CEO of New Mexico Top Organics-Ultra Health, the state’s largest medical cannabis company, said he has concerns over provisions in the state law that caps plant production at 20,000 per grower but allows an unlimited number of retail licenses.

“We will probably need to pare back as many as 100 locations,” he predicted, “and there will be a lot of small business that will be hurt very badly.”

Thomson said that the launch of sales could be blunted as some retailers are still navigating local rules and awaiting final municipal approval.

End

Florida Judge Exonerates Doctor Accused of Violating Medical Cannabis Law

3/22/2022

by

a word from our sponsors:

advertisement

advertise here

A Florida administrative law judge last week ruled that Dr. Joseph Dorn didn’t do anything wrong when he ordered medical cannabis for two undercover investigators posing as patients, the Tallahassee Democrat reports. The state Department of Health (DOH) had sought to revoke Dorn’s medical license for five years, permanently ban him from recommending medical cannabis, and impose a $10,000 fine.

The Health Department had alleged Dorn violated state law by not performing physicals on the undercover agents who posed as patients seeking medical cannabis cards, which they called employing a “trick or scheme” in the practice of medicine.

Dorn has practiced medicine in Florida for more than 30 years and the allegations stem from a 2019 complaint related to the sting.

In his order, Administrative Law Judge W. David Watkins recommended that the complaint against Dorn be dismissed, saying that health officials “failed to present competent substantial evidence, in this case, establishing … that Dr. Dorn acted, or failed to act, in any manner to defraud or trick any patient, or that any patient was actually defrauded or tricked,” according to the Democrat report.

“The evidence of record undermines DOH’s argument that Dr. Dorn’s practice is nothing more than an ‘open gate’ to medical marijuana. In the case of both [undercover agent] O.G. and [undercover agent] B.D. (and presumably the other 28 patients examined), Dr. Dorn conducted a detailed and thorough assessment of the patient’s condition prior to prescribing medical marijuana. Furthermore, the preponderance of the competent substantial evidence in this case demonstrates that Dr. Dorn performed a meaningful review of O.G. and B.D.’s medical history and symptoms, identified and discussed their qualifying stressors, and noted the PTSD (post-traumatic stress disorder) symptoms being experienced by each.” – Watkins, in his opinion, via the Democrat

Under administrative law, the order will go to the Health Department for final action.

In a prepared statement following the ruling, Dorn’s attorney, Ryan Andrews, accused the state of “inflicting crippling stress and pain” on his client as the doctor continued to treat patients following the investigation. Andrews threatened to take legal action against state officials involved in the complaint.

“This action didn’t sound in good faith and now it’s our turn to seek justice and right this wrong against everyone involved,” Andrews said in the statement. “This entire action against Dr. Dorn is an embarrassment and disservice to the state of Florida. Dr. Dorn is excited to continue treating patients without these baseless and harmful accusations hanging over his head.”

The Health Department did not comment on the ruling.

End

Washington Sees More Violence at Legal Cannabis Shops

3/22/2022

by

a word from our sponsors:

advertisement

advertise here

Legal adult-use cannabis businesses in the Tacoma and Seattle, Washington areas experienced a continued trend of violence over the weekend, the Seattle Times reports. The latest incident happened in Tacoma Saturday night after 10:00 pm when an employee at the licensed cannabis retailer World of Weed was fatally shot during an alleged robbery.

Police and firefighters quickly arrived on the scene but were unable to save the man’s life and police are investigating the shooting as a homicide, the Times reports.

Charles Traversie, a neighbor of the shop, told Seattle’s Fox 13 that World of Weed “never had problems before,” but he “knew sooner or later … it was going to probably get hit soon.”

Just two days earlier, on Thursday, an armed employee at a Covington dispensary fatally shot a man who was attempting to rob the store. Earlier that week, another fatality tied to the cannabis industry took place when police got in a shootout with an armed robbery suspect who was fleeing a Belleview cannabis retailer, the Times says.

Adult-use retail cannabis locations have become targets due to the cash-only nature of the business, which is the result of the substance’s Schedule I status under the federal Controlled Substances Act. Consequently, banks, which are regulated by the federal government, must generally avoid accepting cannabis business deposits or processing debit or credit card payments. This lack of access to banking results in the stores accumulating large amounts of cash throughout the day, which makes them inviting targets for armed robbers.

Federal lawmakers have for years attempted to pass the SAFE Banking Act, which would give cannabis businesses access to the federal banking system, but their efforts have so far failed.

End

South Dakota Gov. Signs Medical Cannabis and Hemp Bills

3/22/2022

by

a word from our sponsors:

advertisement

advertise here

South Dakota Gov. Kristi Noem (R) last week signed six bills related to medical cannabis and hemp which her office said in a press release are designed to implement “a safe and responsible medical cannabis program that is the most patient-focused in the country.”

The bills include SB24 which places a four-plant limit on home grows, allowing two seedlings and two flowering plants; SB26 which allows physician’s assistants and nurse practitioners to certify patients for the program; SB118 which limits medical cannabis batch testing to 50 pounds; SB21 which requires the state Health Department to provide written notice if it revokes a medical cannabis patient card; and SB119 which allows nursing homes, treatment centers, and mental health centers to impose restrictions on cannabis use within their facilities and includes provisions to allow those facilities to choose not to store and administer medical cannabis to clients and patients.

Noem also signed into law SB201 which allows South Dakota’s health secretary to waive the finger-printing requirements for certain hemp cultivators or owners of the property where hemp is grown. The measure also allows hemp producers and manufacturers to temporarily exceed the 0.3% THC limits during certain phases of CBD production.

The bills ultimately made changes to the medical cannabis law approved by 70% of voters during the 2020 General Election. Noem had previously signed an additional 18 medical cannabis bills into law during the 2022 legislation session, her office said.

End